Transforming Patients' Lives

OX1406

 

 

OX1406 (anti beta2-GPI) is a modified antibody which binds to beta 2 glycoprotein I.

 

This product was specifically designed to target the main pathogenetic mechanism of the antiphosholipid syndrome (Hughes syndrome, or APS), a rare disease characterized by multiple and recurrent thromboses.

 

OX1406 prevent thromboses in APS by competing with antiphospholipid antibodies for the binding to beta2-GPI.

 

OX1406 is outlicensed to Aura Biopharm

 

For more information, please see the following references or contact us:

 

Agostinis et al., Blood 2014. 123(22):3478-87

ANTIBODIES TO β2-GLYCOPROTEIN I AND THERAPEUTIC USES THEREOF

 

OncoNOx ApS - Ole Maaløes Vej 3 - 2200 Copenhagen - Denmark